The role of internal and external stimuli in the rational design of skin-specific drug delivery systems

In recent years, nanogels have emerged as promising drug delivery vehicles; their ability in holding active molecules, macromolecules and drugs, together with the capability to respond to external stimuli, makes them a suitable tool for a wide range of applications. These features allow nanogels to be exploited against many challenges of nanomedicine associated with different kinds of pathologies which require the use of specific drug delivery systems. In this review our aim is to give the reader an overview of the diseases that can be treated with nanogels as drug delivery systems, such as cancer, CNS disorders, cardiovascular diseases, wound healing and other diseases of human body. For all of these pathologies, biological in vivo assays can be found in the literature and in this work. We focus on the peculiarities of these nanogels, highlighting their features and their advantages in respect to conventional treatments.

Download Full-text

The effective role of hydroxyapatite-based composites in anti-cancer drug delivery systems

Critical Reviews in Therapeutic Drug Carrier Systems ◽

10.1615/critrevtherdrugcarriersyst.v33.i1.10 ◽

2016 ◽

Vol 33 (1) ◽

Author(s):

Samaneh Saber-Samandari

Keyword(s):

Drug Delivery ◽

Drug Delivery Systems ◽

Delivery Systems ◽

Cancer Drug ◽

Anti Cancer ◽

Effective Role ◽

Cancer Drug Delivery

Download Full-text

Emerging Role of Colloidal Drug Delivery Systems (CDDS) in NSAID Topical Administration

Current Medicinal Chemistry ◽

10.2174/0929867311320140004 ◽

2013 ◽

Vol 20 (14) ◽

pp. 1847-1857 ◽

Cited By ~ 8

Author(s):

Carmelo Puglia ◽

Giorgia Tirendi ◽

Francesco Bonina

Keyword(s):

Drug Delivery ◽

Drug Delivery Systems ◽

Topical Administration ◽

Delivery Systems

Download Full-text

Advances in the use of MOFs for Cancer Diagnosis and Treatment: An Overview

Current Pharmaceutical Design ◽

10.2174/1381612826666200406153949 ◽

2020 ◽

Vol 26 (33) ◽

pp. 4174-4184

Author(s):

Marina P. Abuçafy ◽

Bruna L. da Silva ◽

João A. Oshiro-Junior ◽

Eloisa B. Manaia ◽

Bruna G. Chiari-Andréo ◽

...

Keyword(s):

Drug Delivery ◽

Drug Delivery Systems ◽

Rational Design ◽

Gas Adsorption ◽

Drug Loading ◽

Drug Carriers ◽

Delivery Systems ◽

Academic Community ◽

Anticancer Drug Delivery ◽

Diagnostic Agents

Nanoparticles as drug delivery systems and diagnostic agents have gained much attention in recent years, especially for cancer treatment. Nanocarriers improve the therapeutic efficiency and bioavailability of antitumor drugs, besides providing preferential accumulation at the target site. Among different types of nanocarriers for drug delivery assays, metal-organic frameworks (MOFs) have attracted increasing interest in the academic community. MOFs are an emerging class of coordination polymers constructed of metal nodes or clusters and organic linkers that show the capacity to combine a porous structure with high drug loading through distinct kinds of interactions, overcoming the limitations of traditional drug carriers explored up to date. Despite the rational design and synthesis of MOFs, structural aspects and some applications of these materials like gas adsorption have already been comprehensively described in recent years; it is time to demonstrate their potential applications in biomedicine. In this context, MOFs can be used as drug delivery systems and theranostic platforms due to their ability to release drugs and accommodate imaging agents. This review describes the intrinsic characteristics of nanocarriers used in cancer therapy and highlights the latest advances in MOFs as anticancer drug delivery systems and diagnostic agents.

Download Full-text

Role of novel drug delivery systems in coronavirus disease-2019 (covid-19): time to act now

Current Drug Delivery ◽

10.2174/1567201817666200916090710 ◽

2020 ◽

Vol 17 ◽

Author(s):

Neeraj Mittal ◽

Varun Garg ◽

Sanjay Kumar Bhadada ◽

O. P. Katare

Keyword(s):

Drug Delivery ◽

Targeted Delivery ◽

Drug Delivery Systems ◽

Delivery Systems ◽

World Health ◽

Ongoing Research ◽

Standard Drug ◽

Corona Virus ◽

Novel Drug

: The corona virus disease 2019 (COVID-19) has found its roots from Wuhan (China). COVID-19 is caused by a novel corona virus SARS-CoV2, previously named as 2019-nCoV. COVID-19 has spread across the globe and declared as pandemic by World health organization (WHO) on 11th March, 2020. Currently, there is no standard drug or vaccine available for the treatment, so repurposing of existing drugs is the only solution. Novel drug delivery systems (NDDS) will be boon for the repurposing of drugs. The role of various NDDS in repurposing of existing drugs for treatment of various viral diseases and their relevance in COVID-19 has discussed in this paper. It focuses on the currently ongoing research in the implementation of NDDS in COVID-19. Moreover it describes the role of NDDS in vaccine development for COVID-19. This paper also emphasizes how NDDS will help to develop the improved delivery systems (dosage forms) of existing therapeutic agents and also explore the new insights to find out the void spaces for a potential targeted delivery. So in these tough times, NDDS and nanotechnology can be a safeguard to humanity.

Download Full-text